Investing.com - Inogen Inc (NASDAQ: INGN) reported fourth quarter EPS of $-1.14, $0.51 worse than the analyst estimate of $-0.63. Revenue for the quarter came in at $75.9M versus the consensus estimate of $77M.
Guidance
Inogen Inc sees Q1 2024 revenue of $73.00M-$74.00M versus the analyst consensus of $80.60M.
Inogen Inc's stock price closed at $9.34. It is up 63.29% in the last 3 months and down -40.40% in the last 12 months.
Inogen Inc saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Inogen Inc's stock price’s past reactions to earnings here.
According to InvestingPro, Inogen Inc's Financial Health score is "good performance".
Check out Inogen Inc's recent earnings performance, and Inogen Inc's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar